PRESENTATION TITLE
Non-Hodgkin Lymphoma Prognosis and Survivorship: A Clinical Epidemiology Perspective

PRESENTER(S)
James R. Cerhan, M.D., Ph.D., Professor of Epidemiology, Department of Quantitative Health Sciences | Ralph S. and Beverly Caulkins Professor of Cancer Research | Co-Leader, Population Sciences Program, Mayo Clinic Cancer Center | Mayo Clinic, Rochester, Minnesota

PRESENTER BIO
James Cerhan, M.D., Ph.D., received his MD and PhD from the University of Iowa and completed a post-doctoral fellowship in cancer epidemiology at the University of Minnesota. He joined Mayo Clinic in 1998, where he has served as Chair of the Division of Epidemiology (2006-2012), Chair of the Department of Health Sciences Research (2012-2020), and Co-Leader of the Genetic Epidemiology and Risk Assessment Program (2002-2019) among other leadership roles. Dr. Cerhan uses epidemiologic approaches to study the causes and outcomes of cancer in human populations. His major contributions have been on identifying genetic, environmental, lifestyle, and biological factors that are responsible for causing lymphoma and improving the outcomes of patients with lymphoma. His program has been continuously funded by the National Institutes of Health (NIH) since 1995, and he has published over 500 papers in the peer-reviewed literature. He has also provided extensive service to the NIH (including chairing the NCI Cohort Consortium from 2011-2012), American Association for Cancer Research (including chairing the Molecular Epidemiology Group from 2012-2013), American Cancer Society (including chairing the Council of Extramural Grants from 2015-2017), Lymphoma Research Foundation (currently serving on the Scientific Advisory Board), and the International Agency for Research on Cancer (IARC) in Lyon, France (serving as the US representative on the Scientific Council from 2018-2022). He has served on several editorial boards and as a senior editor for the fourth edition of Schottenfeld and Fraumeni’s Cancer Epidemiology and Prevention. Dr. Cerhan has received many awards and honors, including election into the American Epidemiological Society in 2008.

VIEWING LOCATIONS
Zoom Registration

LEARNING OBJECTIVES
Upon conclusion of this activity, participants will be able to:

• Summarize the descriptive epidemiology of non-Hodgkin lymphoma (NHL) and how this drives the number of long-term survivors
• Recognize the role of host factors in NHL prognosis and survivorship
• Describe the strengths and limitations of using observational study designs for outcomes research, patient care and evaluation of efficacy of clinical interventions

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.